The application of a murine bone bioreactor as a model of tumor: Bone interaction

Clinical and Experimental Metastasis

Volumn 23, Issue 7-8, 2006, Pages 345-356

  Halpern, Jennifer ^a   Lynch, Conor C ^a,b   Fleming, Jonathan ^b   Hamming, David ^a   Martin, Michelle D ^b   Schwartz, Herbert S ^a   Matrisian, Lynn M ^b   Holt, Ginger E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Bioreactor; BMP 2; Bone imaging; Bone morphogenetic protein 2; Bone tissue engineering; Breast to bone metastasis; Ectopic bone; Osteoblast; Osteoclast; Osteoid; Polyoma virus Middle T; PyMT; Tumor bone interaction

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; HYDROXYAPATITE; LUCIFERASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOREACTOR; BONE DEVELOPMENT; BREAST TUMOR; CARCINOGENESIS; COMPARATIVE STUDY; FEMORAL ARTERY; GROWTH RATE; MORPHOGENESIS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOID; OSTEOLYSIS; POLYOMA VIRUS; PROTEIN EXPRESSION; TISSUE ENGINEERING; TUMOR CELL LINE; TUMOR GROWTH; TUMOR MODEL;

ANIMALS; BIOREACTORS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; BONE NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DURAPATITE; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 33846676964     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-006-9044-8     Document Type: Article

References (45)

1. Yoshikawa H, Myoui A (2005) Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs 8:131-136
2. Holt GE, Halpern JL, Dovan TT et al (2005) Evolution of an in vivo bioreactor. J Orthop Res 23:916-923
3. Wozney JM, Rosen V, Celeste AJ et al (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534
4. Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22:233-241
5. Bianco P, Robey PG (2001) Stem cells in tissue engineering. Nature 414:118-121
6. Bruder SP, Fox BS (1999) Tissue engineering of bone. Cell based strategies. Clin Orthop Relat Res 367S:S68-S83
7. Reddi AH (1998) Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16:247-252
8. Clines GA, Guise TA (2005) Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer 12:549-583
9. Keller ET, Brown J (2004) Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J Cell Biochem 91:718-729
10. Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655-1664
11. Guise TA, Chirgwin JM (2003) Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin Orthop Relat Res 415S:S32-S38
12. Ritchie CK, Andrews LR, Thomas KG et al (1997) The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease. Endocrinology 138:1145-1150
13. Goya M, Miyamoto S, Nagai K et al (2004) Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors. Cancer Res 64:6252-6258
14. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584-593
15. Guise TA, Yin JJ, Taylor SD et al (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544-1549
16. Zhang J, Dai J, Qi Y et al (2001) Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest 107:1235-1244
17. Thomas RJ, Guise TA, Yin JJ et al (1999) Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140:4451-4458
18. Nelson JB, Nguyen SH, Wu-Wong JR et al (1999) New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade. Urology 53:1063-1069
19. Welch DR, Harms JF, Mastro AM et al (2003) Breast cancer metastasis to bone: evolving models and research challenges. J Musculoskelet Neuronal Interact 3:30-38
20. Arguello F, Baggs RB, Frantz CN (1988) A murine model of experimental metastasis to bone and bone marrow. Cancer Res 48:6876-6881
21. Yoneda T, Williams PJ, Hiraga T et al (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16:1486-1495
22. Corey E, Quinn JE, Bladou F et al (2002) Establishment and characterization of osseous prostate cancer models: intratibial injection of human prostate cancer cells. Prostate 52:20-33
23. Singh AS, Figg WD (2005) In vivo models of prostate cancer metastasis to bone. J Urol 174:820-826
24. Harms JF, Welch DR, Samant RS et al (2004) A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. Clin Exp Metastasis 21:119-128
25. Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537-549
26. Roy DM, Linnehan SK (1974) Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange. Nature 247:220-222
27. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12:954-961
28. Seeman E, Delmas PD (2006) Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med 354:2250-2261
29. Helfrich MH, Ralston SH (2003) Bone Research Protocols. Humana Press, USA
30. Jarcho M (1981) Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop Relat Res 157:259-278
31. Hench LL, Wilson J (1984) Surface-active biomaterials. Science 226:630-636
32. Ripamonti U, Schnitzler CM, Cleaton-Jones PC (1989) Bone induction in a composite allogeneic bone/alloplastic implant. J Oral Maxillofac Surg 47:963-969
33. Ripamonti U (1996) Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 17:31-35
34. Irie K, Alpaslan C, Takahashi K et al (2003) Osteoclast differentiation in ectopic bone formation induced by recombinant human bone morphogenetic protein 2 (rhBMP-2). J Bone Miner Metab 21:363-369
35. Saito A, Suzuki Y, Ogata S et al (2004) Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide. J Biomed Mater Res A 70:115-121
36. Redey SA, Razzouk S, Rey C et al (1999) Osteoclast adhesion and activity on synthetic hydroxyapatite, carbonated hydroxyapatite, and natural calcium carbonate: relationship to surface energies. J Biomed Mater Res 45:140-147
37. Botelho CM, Brooks RA, Spence G et al (2006) Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite. J Biomed Mater Res A 78(4):709-720
38. Kaneko H, Arakawa T, Mano H et al (2000) Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27:479-486
39. Itoh K, Udagawa N, Katagiri T et al (2001) Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 142:3656-3662
40. Lelekakis M, Moseley JM, Martin TJ et al (1999) A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 17:163-170
41. Yoneda T, Sasaki A, Mundy GR (1994) Osteolytic bone metastasis in breast cancer. Breast Cancer Res Tr 32:73-84
42. de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24-37
43. Fournier PG, Chirgwin JM, Guise TA (2006) New insights into the role of T cells in the vicious cycle of bone metastases. Curr Opin Rheumatol 18:396-404
44. Langenfeld EM, Kong Y, Langenfeld J (2005) Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 25(5):685-692
45. Bakewell SJ, Nestor P, Prasad S et al (2003) Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proc Natl Acad Sci USA 100:14205-14210